Terms: = Lung cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Treatment
350 results:
1. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
[TBL] [Abstract] [Full Text] [Related]
2. Disease control in patients with non-small cell lung cancer using pemetrexed: Investigating the best treatment strategy.
Takahara Y; Abe R; Sumito N; Tanaka T; Ishige Y; Shionoya I; Yamamura K; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T
Thorac Cancer; 2024 Apr; 15(12):987-993. PubMed ID: 38485287
[TBL] [Abstract] [Full Text] [Related]
3. [A case of immune-related gastroesophagitis with laryngopharyngitis caused by immune checkpoint inhibitors in nonsmall cell lung cancer].
Oka Y; Hamano Y; Nakamura R; Mabuchi K; Ochi M; Yamaguchi Y; Okawara H; Okawara A; Kakinoki N; Kamoshida T
Nihon Shokakibyo Gakkai Zasshi; 2024; 121(3):221-229. PubMed ID: 38462470
[TBL] [Abstract] [Full Text] [Related]
4. An Unusual Presentation of Choriocarcinoma in a Postmenopausal Woman: A case report.
Zribi A; Mazroui RA; Sayani R; Burney IA
Sultan Qaboos Univ Med J; 2024 Feb; 24(1):135-138. PubMed ID: 38434469
[TBL] [Abstract] [Full Text] [Related]
5. Primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion: a literature review.
Miao X; Chen J; Yang L; Lu H
J Cancer Res Clin Oncol; 2024 Feb; 150(3):108. PubMed ID: 38421462
[TBL] [Abstract] [Full Text] [Related]
6. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the treatment of TA-muc1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract] [Full Text] [Related]
7. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.
Kosumi T; Kobayashi M; Shimodaira S; Sugiyama H; Koido S
J Med Case Rep; 2024 Feb; 18(1):88. PubMed ID: 38336778
[TBL] [Abstract] [Full Text] [Related]
8. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
9. Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.
Liu L; Li L; Ding Y; Kong F; Mo W; Ye H; Shen D
Diagn Pathol; 2024 Jan; 19(1):19. PubMed ID: 38254207
[TBL] [Abstract] [Full Text] [Related]
10. Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
Kozai H; Ogino H; Mitsuhashi A; Nguyen NT; Tsukazaki Y; Yabuki Y; Ozaki R; Yoneda H; Sato S; Hanibuchi M; Shinohara T; Nokihara H; Nishioka Y
Thorac Cancer; 2024 Feb; 15(5):369-378. PubMed ID: 38146645
[TBL] [Abstract] [Full Text] [Related]
11. Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is muc1 the one?
van Horik C; Zuidweg MJP; Boerema-de Munck A; Buscop-van Kempen M; Brosens E; Vahrmeijer AL; von der Thüsen JH; Wijnen RMH; Rottier RJ; Tummers WSFJ; Schnater JM
Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 38123235
[TBL] [Abstract] [Full Text] [Related]
12. A rare report of a metastatic lung large-cell neuroendocrine carcinoma in palatine tonsil.
Scarini JF; de Oliveira VC; de Arruda TA; Chone CT; Rogério F; Egal ÉSA; Altemani A; Mariano FV
Oral Oncol; 2023 Dec; 147():106606. PubMed ID: 38047539
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Stage Ⅳc dMMR Transverse Colon cancer with Complete Response to Combination Therapy with Immune Checkpoint Inhibitor in Stage ⅣB lung Adenocarcinoma].
Kageyama C; Yoshimatsu K; Tanaka H; Higashida M; Ito Y; Okada T; Endo S; Fujiwara Y; Ueno T
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1114-1116. PubMed ID: 38035848
[TBL] [Abstract] [Full Text] [Related]
14. Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in lung cancer: An Italian Expert Panel Discussion.
Gridelli C; Tiseo M; Cortinovis DL; Migliorino MR; Barbieri V; Bironzo P; Bearz A; Attili I; de Marinis F
Curr Oncol; 2023 Nov; 30(11):10033-10042. PubMed ID: 37999149
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III study.
Chen L; Rangel JDG; Cil T; Li X; Cicin I; Shen Y; Liu Z; Ozyilkan O; Igor B; Chen J; Oleksandr K; Chen Z; Zhang H; Fu Z; Dong Q; Song S; Yu JC; Zhang L
Cancer Med; 2023 Nov; 12(22):20847-20863. PubMed ID: 37935428
[TBL] [Abstract] [Full Text] [Related]
16. muc1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N; Ozawa H; Morimoto Y; Yamashita N; Daimon T; Bhattacharya A; Wang K; Nakashoji A; Isozaki H; Shimokawa M; Kikutake C; Suyama M; Hashinokuchi A; Takada K; Takenaka T; Yoshizumi T; Mitsudomi T; Hata AN; Kufe D
J Thorac Oncol; 2024 Mar; 19(3):434-450. PubMed ID: 37924972
[TBL] [Abstract] [Full Text] [Related]
17. Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS.
Genet SAAM; van den Wildenberg SAH; Broeren MAC; van Dongen JLJ; Brunsveld L; Scharnhorst V; van de Kerkhof D
Clin Chem Lab Med; 2024 Mar; 62(4):720-728. PubMed ID: 37886827
[TBL] [Abstract] [Full Text] [Related]
18. Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials.
Messori A; Rivano M; Chiumente M; Mengato D
Chin Clin Oncol; 2023 Oct; 12(5):50. PubMed ID: 37817505
[TBL] [Abstract] [Full Text] [Related]
19. Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma.
Ng HY; Ko JMY; Lam KO; Kwong DLW; Lo AWI; Wong IYH; Wong CLY; Chan SY; Chan KK; Law TT; Dai W; Fong HCH; Choy FSF; Lo CK; Chen C; Law SYK; Lung ML
JAMA Surg; 2023 Nov; 158(11):1141-1150. PubMed ID: 37728901
[TBL] [Abstract] [Full Text] [Related]
20. A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.
Yabuki Y; Hanibuchi M; Takeuchi E; Haku T; Kanematsu T; Nishimura N; Toyoda Y; Mitsuhashi A; Otsuka K; Sato S; Goto H; Yoneda H; Ogino H; Nokihara H; Tsutomu S; Nishioka Y
Thorac Cancer; 2023 Nov; 14(32):3232-3239. PubMed ID: 37718463
[TBL] [Abstract] [Full Text] [Related]
[Next]
